Login
$CSBR
$4.56 -$0.15 (3.08%) Live

$CSBR SEC Filings

Filed On Filing
09 Nov 2026 Form 4: Sidransky David, Director

Granted 31,216 Option to purchase Common Stock ($149K)

09 Nov 2026 Form 4: Mendelson Daniel Newman, Director

Granted 20,291 Option to purchase Common Stock ($96.6K)

09 Nov 2026 Form 4: Tobin Scott R, Director

Granted 37,460 Option to purchase Common Stock ($178K)

09 Nov 2026 Form 4: Ackerman Joel, Director

Granted 31,216 Option to purchase Common Stock ($149K)

16 Oct 2026 Form 4: Ackerman Joel, Director

Received 69,794 shares by exercise or conversion ($112K)

16 Oct 2026 8-K: Submission of Matters to a Vote of Security Holders

On October 14, 2026, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results...

11 Sep 2026 10-Q
10 Sep 2026 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

28 Aug 2026 DEFA14A
28 Aug 2026 Proxy statement: annual meeting on October 14, 2026

CEO pay $3.6M · say-on-pay vote

27 Jul 2026 10-K
27 Jul 2026 8-K: Results of Operations and Financial Condition

Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA

30 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

12 Mar 2026 10-Q
12 Mar 2026 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

30 Jan 2026 Form 4: Brainin Robert Lawrence, Director

Granted 700,000 Option to purchase Common Stock ($5.46M)

30 Jan 2026 Form 4: Brainin Robert Lawrence, Director

Granted 9,901 Option to purchase Common Stock ($100K) · Granted 14,130 Option to purchase Common Stock ($98.9K) · Granted 19,070 Option to purchase Common Stock ($105K) · 1 more

16 Jan 2026 Form 3: Brainin Robert Lawrence, Director
15 Dec 2025 10-Q
15 Dec 2025 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support